Minerva Neurosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease.
CEORémy Henri Luthringer
CEORémy Henri Luthringer
Employees8
Employees8
HeadquartersBurlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded2007
Founded2007
Employees8
Employees8
NERV Key Statistics
Market cap13.92M
Market cap13.92M
Price-Earnings ratio2.41
Price-Earnings ratio2.41
Dividend yield—
Dividend yield—
Average volume25.00K
Average volume25.00K
High today$2.14
High today$2.14
Low today$1.99
Low today$1.99
Open price$2.00
Open price$2.00
Volume6.64K
Volume6.64K
52 Week high$3.38
52 Week high$3.38
52 Week low$1.15
52 Week low$1.15
People also own
Based on the portfolios of people who own NERV. This list is generated using Robinhood data, and it’s not a recommendation.